Zoetis Plans Financial Results Call Amid Commitment to Animal Health Innovation

Zoetis Prepares for Key Financial Results Discussion Amidst Ongoing Commitment to Animal Health

Zoetis Inc., the leading global animal health company, announces its plans for a webcast and conference call scheduled for February 13, 2025. This event, set to begin at 8:30 a.m. ET, aims to discuss the company's fourth quarter and full year 2024 financial results. CEO Kristin Peck and CFO Wetteny Joseph will lead the presentation, providing an overview of the company’s performance and addressing inquiries from financial analysts. The webcast will be accessible to both investors and the public via Zoetis' investor relations website, with details for pre-registration available immediately. A replay of the discussion will also be made available later the same day, allowing for broader engagement with stakeholders.

As Zoetis approaches this financial briefing, it underscores its ongoing commitment to enhancing animal care through innovative solutions. With a robust portfolio that includes medicines, vaccines, diagnostics, and technologies, Zoetis serves a diverse range of stakeholders including veterinarians, pet owners, and livestock farmers across more than 100 countries. The company’s mission reflects its dedication to improving animal health and welfare, a focus that has enabled Zoetis to report significant revenue of $8.5 billion in 2023. With a workforce of approximately 14,100 employees, Zoetis positions itself not just as a commercial entity but as a critical player in the global effort to nurture animal health and, by extension, human health.

The upcoming conference call is also pivotal for investors looking to gauge the company’s financial trajectory and strategic direction. The emphasis on transparency during these calls aligns with Zoetis' long-standing practice of keeping its stakeholders informed. By facilitating an open dialogue, Zoetis not only reinforces investor confidence but also highlights its commitment to accountability. As the company prepares to unveil its financial results, the anticipation surrounding the call reflects the broader interest in animal health markets, where Zoetis continues to lead through innovation and responsiveness to stakeholder needs.

In addition to the upcoming financial results discussion, Zoetis has recently gained recognition from BetterInvesting Magazine as a "Stock to Study" in its March 2025 issue. This acknowledgment has spurred dialogue among investors regarding the company’s valuation metrics, emphasizing the comprehensive data available for analysis. BetterInvesting, a nonprofit organization dedicated to investment education, encourages individuals to engage with the provided resources to enhance their financial literacy and investment strategies.

Through its commitment to advancing animal health and fostering educational initiatives, Zoetis continues to carve out a significant role in the industry, demonstrating its leadership not only in financial performance but also in the welfare of animals worldwide.